本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

PMV Pharmaceuticals

1.41
-0.0300-2.08%
盘后1.410.00000.00%16:11 EDT
成交量:28.59万
成交额:40.17万
市值:7,325.33万
市盈率:-1.20
高:1.47
开:1.44
低:1.37
收:1.44
数据加载中...
2023/05/10

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/04/28

重要事件披露

8-K - Current report
2023/03/01

重要事件披露

8-K - Current report
2023/03/01

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/09

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/01/25

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2023/01/25

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/01/24

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/11/08

重要事件披露

8-K - Current report
2022/11/08

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/11/04

重要事件披露

8-K - Current report
2022/08/09

重要事件披露

8-K - Current report
2022/08/09

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/07/07

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/06/17

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals